Want to master the CMO role? Join us for GrowthBeat Summit on June 1-2 in Boston
, where we'll discuss how to merge creativity with technology to drive growth. Space is limited and we're limiting attendance to CMOs and top marketing execs. Request your personal invitation here
IlluminOss Medical gets $11M for bone-fracture devices — East Providence, R.I.-based IlluminOss Medical, a medical-device startup, raised $11 million in a second funding round, peHUB reports. Backers included New Leaf Ventures and Foundation Medical Partners.
The company’s Web site is barely more than a stub that describes IlluminOss as a device company “pioneering new frontiers in orthopedic surgery.” peHUB offers the further tidbit that the company is developing a minimally invasive system for treating bone fractures.
We’ve previously covered Sonoma Orthopedics Products, a California firm with what may be a similar technology for treating fractures with an implant that supposedly speeds healing from inside the bone.
Contract researcher Crown Bioscience takes in funding – Crown Bioscience, a biology-services startup in Santa Clara, Calif., raised an undisclosed sum in a second funding round. Chemizon, a division of Optomagic, provided the cash.
Crown offers a variety of biology-based services, including protein characterization, drug-candidate discovery and assessment of anticancer drugs. In other words, it’s a contract-research organization, although it seems to have a wider range of offerings that many CROs do.
VentureBeat’s VB Insight team is studying email marketing tools.
Chime in here, and we’ll share the results